1. Home
  2. ITRG vs NTRB Comparison

ITRG vs NTRB Comparison

Compare ITRG & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integra Resources Corp.

ITRG

Integra Resources Corp.

HOLD

Current Price

$4.35

Market Cap

482.5M

ML Signal

HOLD

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$4.55

Market Cap

71.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRG
NTRB
Founded
1997
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Industrial Specialties
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.5M
71.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ITRG
NTRB
Price
$4.35
$4.55
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$4.13
$13.00
AVG Volume (30 Days)
1.8M
21.4K
Earning Date
11-12-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$219,125,000.00
$2,278,321.00
Revenue This Year
$1,016.77
$30.17
Revenue Next Year
$7.81
$3,394.36
P/E Ratio
$55.52
N/A
Revenue Growth
N/A
12.69
52 Week Low
$0.79
$3.72
52 Week High
$4.69
$11.78

Technical Indicators

Market Signals
Indicator
ITRG
NTRB
Relative Strength Index (RSI) 68.71 44.63
Support Level $4.01 $4.34
Resistance Level $4.69 $4.77
Average True Range (ATR) 0.25 0.38
MACD 0.02 0.04
Stochastic Oscillator 70.75 35.93

Price Performance

Historical Comparison
ITRG
NTRB

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: